PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23517575-10 2013 cyclophosphamide pulses monthly for 6 doses, followed by mycophenolate mofetil that resulted in normal lung function tests, hemoglobin concentration, and anti-MPO level within four subsequent weeks. Mycophenolic Acid 57-78 myeloperoxidase Homo sapiens 159-162 30918194-5 2019 Corticosteroids and mycophenolate mofetil were administered as for ANCA vasculitis, and the serum creatinine, abnormal urinalysis and MPO-ANCA titer all gradually ameliorated. Mycophenolic Acid 20-41 myeloperoxidase Homo sapiens 134-137 31253599-4 2019 The purpose of this study was to compare the efficacy and safety of mycophenolate mofetil versus cyclophosphamide for the induction treatment of nonlife-threatening relapses of proteinase 3-ANCA- and myeloperoxidase-ANCA-associated vasculitis. Mycophenolic Acid 68-89 myeloperoxidase Homo sapiens 177-215 18538114-0 2008 Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity. Mycophenolic Acid 0-21 myeloperoxidase Homo sapiens 30-33 35064793-13 2022 The combined effects of myeloperoxidase concentration and renal function resulted in a sixfold range of MPA dose. Mycophenolic Acid 104-107 myeloperoxidase Homo sapiens 24-39